{"entity":{"type":"insider","cik":"0001877680","url":"/insider/0001877680","json_url":"/insider/0001877680.json","name":"Ellis Andrea","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2022-03-17","last":"2026-07-13","span_basis":"filed_date"},"name_variants":[{"name":"Ellis Andrea","source":"filing","n_filings":6,"first_seen":"2022-03-17","last_seen":"2026-07-13"}],"transactions":[{"id":6148071,"accession":"0001470831-26-000709","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-26-000709","line_url":"/filing/0001470831-26-000709#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001877680","owner_name":"Ellis Andrea","owner_display_name":"Ellis Andrea","owner_url":"/insider/0001877680","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17167.0,"shares_display":"17,167","price_per_share":84.0,"price_display":"84.00","price_state":"stated","total_value":1442028.0,"total_display":"1,442,028.00","total_whole":"1,442,028","shares_owned_after":22579.0,"shares_owned_after_display":"22,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-13","scope":"insider"},{"id":6092780,"accession":"0001470831-26-000252","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-26-000252","line_url":"/filing/0001470831-26-000252#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001877680","owner_name":"Ellis Andrea","owner_display_name":"Ellis Andrea","owner_url":"/insider/0001877680","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64921.0,"shares_display":"64,921","price_per_share":64.8681,"price_display":"64.87","price_state":"stated","total_value":4211301.9201,"total_display":"4,211,301.92","total_whole":"4,211,302","shares_owned_after":18589.0,"shares_owned_after_display":"18,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-04","filed_date":"2026-03-06","scope":"insider"},{"id":4662514,"accession":"0000950170-25-105185","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-105185","line_url":"/filing/0000950170-25-105185#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001877680","owner_name":"Ellis Andrea","owner_display_name":"Ellis Andrea","owner_url":"/insider/0001877680","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17167.0,"shares_display":"17,167","price_per_share":49.0,"price_display":"49.00","price_state":"stated","total_value":841183.0,"total_display":"841,183.00","total_whole":"841,183","shares_owned_after":18589.0,"shares_owned_after_display":"18,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-05","filed_date":"2025-08-07","scope":"insider"},{"id":4312792,"accession":"0000950170-25-054883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-054883","line_url":"/filing/0000950170-25-054883#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001877680","owner_name":"Ellis Andrea","owner_display_name":"Ellis Andrea","owner_url":"/insider/0001877680","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":350000.0,"total_display":"350,000.00","total_whole":"350,000","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-14","filed_date":"2025-04-16","scope":"insider"},{"id":4059725,"accession":"0000950170-25-050584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-050584","line_url":"/filing/0000950170-25-050584#line-2","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001877680","owner_name":"Ellis Andrea","owner_display_name":"Ellis Andrea","owner_url":"/insider/0001877680","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":34.05,"price_display":"34.05","price_state":"stated","total_value":1021500.0,"total_display":"1,021,500.00","total_whole":"1,021,500","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-01","filed_date":"2025-04-03","scope":"insider"},{"id":6620025,"accession":"0000899243-22-011386","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-011386","line_url":"/filing/0000899243-22-011386#line-1","is_derivative":false,"issuer_cik":"0001743881","issuer_name":"BridgeBio Pharma, Inc.","issuer_ticker":"BBIO","issuer_name_source":null,"issuer_url":"/issuer/0001743881","owner_cik":"0001877680","owner_name":"Ellis Andrea","owner_display_name":"Ellis Andrea","owner_url":"/insider/0001877680","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12000.0,"shares_display":"12,000","price_per_share":8.39,"price_display":"8.39","price_state":"stated","total_value":100680.0,"total_display":"100,680.00","total_whole":"100,680","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001743881","name":"BridgeBio Pharma, Inc.","url":"/issuer/0001743881","role":"Director","n_filings":6,"first_seen":"2022-03-17","last_seen":"2026-07-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001877680","retrieved_at":"2026-08-26T06:50:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}